Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL

Rui Li, Hao Yang, Dianlong Jia, +6

Journal of Controlled Release

MedicineCell TraffickingCell-matrix InteractionHuman TrailTumor Targeting +8

Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy

Haijun Wang, Dianlong Jia, Dandan Yuan, +7

Journal of Nanobiotechnology

Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents

Ming Zhang, Linming Li, Suying Li, +7

Journal of Medicinal Chemistry

Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects

Hao Yang, Yanru Feng, Huawei Cai, +9

Theranostics

Modulation of pericytes by a fusion protein comprising of a PDGFRβ-antagonistic affibody and TNFα induces tumor vessel normalization and improves chemotherapy

Qing Fan, Ze Tao, Hao Yang, +7

Journal of Controlled Release

Tumor BiologyAngiogenesisFusion Protein ComprisingImmunologyVascular Biology +9

Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models

Dianlong Jia, Yujiao Yang, Fengjiao Yuan, +9

International Journal of Pharmaceutics

Tumor BiologyMedicinePharmacologyEgfr-expressing Tumor ModelsAntitumor Efficacy +8

Multi-specific niflumic acid platinum(<scp>iv</scp>) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage

Linming Li, Ming Zhang, Dianlong Jia, +6

Dalton Transactions

Enhancing the circulating half-life and the antitumor effects of a tumor-selective cytotoxic peptide by exploiting endogenous serum albumin as a drug carrier

Tao Su, Hao Yang, Qing Fan, +4

International Journal of Pharmaceutics

Tumor BiologyMedicinePeptide LibraryPharmacologyImmunology +11

Her3-specific affibody mediated tumor targeting delivery of ICG enhanced the photothermal therapy against Her3-positive tumors

Huimin Liu, Dianlong Jia, Fengjiao Yuan, +8

International Journal of Pharmaceutics

Her3-specific AffibodyPhotodynamic TherapyHer3-positive TumorsTumor TargetingCell Biology +4

Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer

Rui Chang, Xiaohong Chu, Jibing Zhang, +7

Molecules

Liposome-based Co-immunotherapyImmunologyImmune RegulationTlr AgonistImmunoediting +24